EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 3.0

Cancer Immunotherapy for Hepatocellular Carcinoma: Current Drug Strategies, Resistance, Biomarkers, and Future Directions

Si-Si Zhong iD, Yang Yu, Xiao-Hui Zhong iD, Jun Xie, Mao-Sheng Liu iD

Drug Design, Development and Therapy · 2026-11 · Volume 20 · 1-32

DOI: 10.2147/dddt.s653279 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Drug Design, Development and Therapy, 2026-11. Verfasst von Si-Si Zhong und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Quality and Safety Management, The First Affiliated Hospital of Gannan Medical University, Ganzhou, Jiangxi, People's Republic of China. Hauptthemen laut MEDLINE: Liver Neoplasms, Carcinoma, Hepatocellular, Immunotherapy, Immune Checkpoint Inhibitors. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver NeoplasmsCarcinoma, HepatocellularImmunotherapyImmune Checkpoint InhibitorsHumansBiomarkers, TumorDrug Resistance, Neoplasm

Stichwörter der Autor:innen

biomarkerscombination therapyhepatic reservehepatocellular carcinomaimmune-checkpoint inhibitorimmunotherapyprecision oncologyresistance

Substanzen

Biomarkers, TumorImmune Checkpoint Inhibitors

Autor:innen und Institutionen

  • Department of Quality and Safety Management, The First Affiliated Hospital of Gannan Medical University, Ganzhou, Jiangxi, People's Republic of China.
  • Department of Gastroenterology, The First Affiliated Hospital of Gannan Medical University, Ganzhou, Jiangxi, People's Republic of China.

ORCID-Profile: Si-Si Zhong, Xiao-Hui Zhong, Mao-Sheng Liu

Zitieren

APA

Zhong, S. S., Yu, Y., Zhong, X. H., Xie, J., & Liu, M. S. (2026). Cancer Immunotherapy for Hepatocellular Carcinoma: Current Drug Strategies, Resistance, Biomarkers, and Future Directions. Drug Design, Development and Therapy, Volume 20, 1-32. https://doi.org/10.2147/dddt.s653279

Vancouver

Zhong SS, Yu Y, Zhong XH, Xie J, Liu MS. Cancer Immunotherapy for Hepatocellular Carcinoma: Current Drug Strategies, Resistance, Biomarkers, and Future Directions. Drug Design, Development and Therapy. 2026;Volume 20:1-32. doi:10.2147/dddt.s653279

BibTeX
@article{Zhong2026,
  author = {Zhong, Si-Si and Yu, Yang and Zhong, Xiao-Hui and Xie, Jun and Liu, Mao-Sheng},
  title = {Cancer Immunotherapy for Hepatocellular Carcinoma: Current Drug Strategies, Resistance, Biomarkers, and Future Directions},
  journal = {Drug Design, Development and Therapy},
  year = {2026},
  volume = {Volume 20},
  pages = {1--32},
  doi = {10.2147/dddt.s653279}
}
Kostenlos starten →